SAGE Open Medical Case Reports (Jun 2024)

Valproate encephalopathy: Case series and literature review

  • Chunhua Pan,
  • Ziyi Zhao,
  • Zheng Liu,
  • Ting Luo,
  • Manmin Zhu,
  • Zucai Xu,
  • Changyin Yu,
  • Hao Huang

DOI
https://doi.org/10.1177/2050313X241260152
Journal volume & issue
Vol. 12

Abstract

Read online

Valproate encephalopathy is one of the unusual and severe but treatable side effect. This research focuses on four female patients who had valproate medication for epilepsy and developed an increased frequency of seizures, exacerbated disruption of consciousness, gastrointestinal problems, cognitive dysfunction, ataxia, and psychobehavioral abnormalities. The patient’s symptoms improved over time once sodium valproate was stopped. As a result, when using sodium valproate, one should be aware of the risk of sodium valproate encephalopathy and cease using the medication right once if any of the above symptoms of unknown etiology manifest clinically. We also go over the potential pathogenesis that lead to valproate encephalopathy and the heightened risk of encephalopathy from taking antiepileptic medications together. It was stressed how crucial it is to identify, diagnose, and treat sodium valproate encephalopathy as soon as possible.